Tag: #ai-chips369 results
Cerebras is facing renewed IPO challenges amid evolving AI chip landscape. Positioned as Nvidia's genuine competitor, the company relies heavily on Middle East client G42. G42 contributed 83% of revenue in 2023 and 87% in 2024.
Tesla is planning to produce humanoid robots in Shanghai, scaling up its Optimus ambitions. TSMC reported Q1 net profit of 5725 billion TWD, exceeding expectations amid AI chip demand. Alibaba's market cap surged over 130 billion HKD in a single day.
Elon Musk's team contacts chip suppliers for Terafab production. This marks early efforts to enter cutting-edge chip manufacturing.
Sequoia-backed Nuvacore seeks to overhaul CPUs for AI. Led by ex-Apple exec Gerard Williams, who sold prior chip venture to Qualcomm. Targets AI chip innovation.
Horizon Robotics, led by founder Yin Qi, reports nearly 10 billion RMB revenue in its first full year with the Journey team. Intelligent driving gross margin reached 30.8%. This marks the first public disclosure of smart driving income.
CITIC report forecasts 4M AI accel cards shipped in China 2025, domestic share over 40% via non-GPU differentiation. Domestic models dominate API calls; Zhipu API prices surge 83% in 2026 Q1 amid shortages. Alibaba's new models and national data registry to accelerate sector growth.
JPMorgan predicts TSMC's 2026 Q1 gross margins to exceed expectations due to tight 3nm capacity, high utilization, and surging AI demand. Price target raised to 2400 NTD amid capex hikes. Q2 revenue growth forecast at 6-8% QoQ despite 3nm limits.
Counterpoint Research predicts 2025 global chip foundry revenue at $320 billion, up 16% YoY, driven by AI accelerator demand. Report introduces 'Foundry 2.0' for complex industry dynamics. TSMC and peers reap massive gains.
Lightelligence filed for a Hong Kong IPO following over $320 million in funding. Backed by Tencent and Baidu, it invests heavily in photonic computing despite R&D-driven losses.
Intel plans to invest another $15M in SambaNova, chaired by CEO Pat Gelsinger, raising its stake to 9% pending approval. This follows a $35M investment in February amid strategic partnership. The move raises conflict-of-interest concerns tied to Gelsinger's investments.